MEDICAMEN BIOTECH LTD.-$
BSE: 531146
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 54.68+25.7% | 43.49+3.0% | 42.23+9.8% | 38.45+47.9% | 26.00-36.8% | 41.14-4.0% | 42.84 |
| Other Income | 1.73+222.7% | 0.53+43.5% | 0.37-20.7% | 0.47-91.0% | 5.22+3601.8% | 0.14-51.4% | 0.29 |
| Total Income | 56.41+28.1% | 44.03+3.4% | 42.60+9.5% | 38.92+24.7% | 31.21-24.4% | 41.28-4.3% | 43.13 |
| EXPENSES | |||||||
| Expenditure | 52.88+29.1% | 40.94+2.8% | 39.83+8.4% | 36.75+30.4% | 28.18-25.5% | 37.80-5.2% | 39.88 |
| Tax | 0.56+14.4% | 0.49-13.3% | 0.56+5.5% | 0.53-15.0% | 0.63-34.4% | 0.95-3.0% | 0.98 |
| PROFIT | |||||||
| PBT | 3.53+14.5% | 3.08+11.3% | 2.77+27.6% | 2.17-28.6% | 3.04-12.7% | 3.48+6.9% | 3.25 |
| Net Profit | 2.97+14.6% | 2.59+17.6% | 2.21+34.8% | 1.64-32.1% | 2.41-4.5% | 2.52+11.2% | 2.27 |
| KEY METRICS | |||||||
| OPM % | 7.55%-4.13pp | 11.68%-0.27pp | 11.95%+1.46pp | 10.49%+14.70pp | -4.21%-5.26pp | 1.05%+2.50pp | -1.45% |
| NPM % | 5.27%-0.62pp | 5.89%+0.71pp | 5.18%+0.97pp | 4.21%-3.51pp | 7.72%+1.61pp | 6.11%+0.85pp | 5.26% |
| EPS | 2.19+14.7% | 1.91+17.2% | 1.63+34.7% | 1.21-36.3% | 1.90-4.0% | 1.98+11.2% | 1.78 |
Corporate Events
Board MeetingMEDICAMEQ
202627May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingMEDICAMEQ
202429May
Board Meeting
Consideration and approval of Audited Financial Results, app…
BSE Filing ↗ Board MeetingMEDICAMEQ
202412Feb
Board Meeting
Consideration and approval of unaudited Financial Results (S…
BSE Filing ↗ Board MeetingMEDICAMEQ
202310Nov
Board Meeting
Consider and approve Unaudited Financial Results for the Qua…
BSE Filing ↗ Board MeetingMEDICAMEQ
20238Aug
Board Meeting
Consideration and approval of Unaudited Financial Results fo…
BSE Filing ↗